Trials / Recruiting
RecruitingNCT01742143
Impact of ICCAN on Cancer Treatment Completion and Quality of Life
A Randomized Controlled Trial of the Impact of ICCAN on Cancer Treatment Completion and Quality of Life
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 347 (estimated)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 21 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this 1 year study is to see if the ICCAN program is working, and to compare the ICCAN program to the standard hospital services provided in New York City hospitals, like meeting with a Social Worker or a Patient Navigator (a person who provides personal hospital guidance).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | The Integrated Cancer Care Access Network (ICCAN) | Patients will receive written materials on social and economic resources and services. Treatment Outcomes Survey at Intake, 3 mo, 6 mo, and 1 year. Chart review at 3 mo, 6 mo and 1 year, and as needed. Plus Initial needs assessment. Assistance with high priority social and economic needs.Monthly follow-up with ICCAN Access Facilitator to address ongoing needs in addition to as-needed assistance. |
| BEHAVIORAL | Usual and Customary Group (U&C) | Patients will receive written materials on social and economic resources and services. Treatment Outcomes Survey at Intake, 3 mo, 6 mo, and 1 year. Chart review at 3 mo, 6 mo and 1 year, and as needed. |
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2026-11-01
- Completion
- 2026-11-01
- First posted
- 2012-12-05
- Last updated
- 2025-12-02
Locations
11 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01742143. Inclusion in this directory is not an endorsement.